Related Experiment Video
Updated: Apr 2, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
1State Key Laboratory of Cellular Stress Biology and School of Life Sciences, Xiamen University, Xiamen, China.
Abstract:
Histone deacetylases (HDACs) are major epigenetic modulators involved in a broad spectrum of human diseases including cancers. As HDACs are promising targets of cancer therapy, it is important to understand the mechanisms of HDAC regulation. In this study, we show that ubiquitin-specific peptidase 4 (USP4) interacts directly with and deubiquitinates HDAC2, leading to the stabilization of HDAC2. Accumulation of HDAC2 in USP4-overexpression cells leads to compromised p53 acetylation as well as crippled p53 transcriptional activation, accumulation and apoptotic response upon DNA damage. Moreover, USP4 targets HDAC2 to downregulate tumor necrosis factor TNFα-induced nuclear factor (NF)-κB activation. Taken together, our study provides a novel insight into the ubiquitination and stability of HDAC2 and uncovers a previously unknown function of USP4 in cancers.
Insights
Ubiquitin-specific peptidase 4 (USP4) stabilizes histone deacetylase 2 (HDAC2), impacting cancer-related pathways like p53 and NF-κB. This reveals a new role for USP4 in cancer.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Biology
Background:
- Histone deacetylases (HDACs) are key epigenetic regulators implicated in various human diseases, notably cancers.
- Understanding HDAC regulation is crucial for developing targeted cancer therapies.
- HDAC2, a specific HDAC, plays a significant role in cellular processes relevant to cancer.
Purpose of the Study:
- To investigate the regulatory mechanism of HDAC2 stability.
- To identify novel interacting partners of HDAC2.
- To elucidate the functional role of USP4 in HDAC2 regulation and its implications in cancer.
Main Methods:
- Co-immunoprecipitation assays to confirm protein-protein interactions between USP4 and HDAC2.
- Western blotting to assess protein levels and acetylation status.
- Cellular assays to evaluate p53 transcriptional activity and apoptotic responses.
- NF-κB reporter assays to measure TNFα-induced activation.
Main Results:
- USP4 directly interacts with and deubiquitinates HDAC2, leading to its stabilization.
- Overexpression of USP4 results in increased HDAC2 levels, decreased p53 acetylation, and impaired p53-mediated transcriptional activation and apoptosis.
- USP4 targets HDAC2 to suppress TNFα-induced NF-κB activation.
Conclusions:
- USP4 deubiquitinates and stabilizes HDAC2, influencing critical cancer-related signaling pathways.
- USP4's regulation of HDAC2 impacts p53 pathway integrity and NF-κB activation, suggesting a novel tumor-suppressive or oncogenic role in cancer.
- This study uncovers a new layer of epigenetic regulation involving USP4 and HDAC2, offering potential therapeutic avenues for cancer treatment.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Co-activators and Co-repressors
Negative Regulator Molecules

